Literature DB >> 15987710

Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.

Cristina Opasich1, Mario Cazzola, Laura Scelsi, Stefania De Feo, Enzo Bosimini, Rocco Lagioia, Oreste Febo, Roberto Ferrari, Alessandro Fucili, Remigio Moratti, Roberto Tramarin, Luigi Tavazzi.   

Abstract

AIMS: Anaemia is often observed in patients with chronic heart failure (CHF), and it may be associated with a worse prognosis. Aim of this study was to identify the individual mechanisms of anaemia in CHF patients. METHODS AND
RESULTS: One hundred and forty-eight consecutive patients with haemoglobin concentration <13 g/dL (if males) or <12 g/dL (if females) were enrolled. Factors responsible for anaemia were investigated by evaluating endogenous erythropoietin (Epo) production, serum cytokines levels, body iron status, and iron supply for erythropoiesis. Most patients (57%) presented anaemia of chronic disease and among them, 92% showed evidence of a defective endogenous Epo production. This was indicated by an observed/predicted log(serum Epo) ratio less than 0.8 and/or a defective iron supply for erythropoiesis diagnosed by low transferrin saturation and/or increased value of soluble transferrin receptor. According to regression analysis sex, renal failure, and serum Epo were correlated with anaemia.
CONCLUSION: According to our study, about half of anaemic CHF patients showed anaemia of chronic disease with blunted endogenous Epo production and/or a defective iron supply for erythropoiesis. Determination of the individual mechanisms of anaemia in CHF could justify a rational therapeutic approach to anaemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987710     DOI: 10.1093/eurheartj/ehi388

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  57 in total

1.  Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.

Authors:  W Khan; S M Deepak; T Coppinger; C Waywell; A Borg; L Harper; S G Williams; N H Brooks
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

2.  Erythropoietin in cardiorenal anemia syndrome.

Authors:  Emir Fazlibegović; Mustafa Hadziomerović; Slavica Corić; Emil Babić; Fadila Fazlibegović
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

3.  Lack of Association Between Anemia and Intrinsic Left Ventricular Diastolic Function or Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction.

Authors:  Jacob A Burns; Cynthia Sanchez; Lauren Beussink; Vistasp Daruwalla; Benjamin H Freed; Senthil Selvaraj; Sanjiv J Shah
Journal:  Am J Cardiol       Date:  2018-07-19       Impact factor: 2.778

4.  Prognostic significance of red cell distribution width and its relation to increased pulmonary pressure and inflammation in acute heart failure.

Authors:  Ryszard Targoński; Janusz Sadowski; Magdalena Starek-Stelmaszczyk; Radosław Targoński; Andrzej Rynkiewicz
Journal:  Cardiol J       Date:  2018-09-20       Impact factor: 2.737

5.  Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.

Authors:  C Berry; K K Poppe; G D Gamble; N J Earle; J A Ezekowitz; I B Squire; J J V McMurray; F A McAlister; M Komajda; K Swedberg; A P Maggioni; A Ahmed; G A Whalley; R N Doughty; L Tarantini
Journal:  QJM       Date:  2015-05-14

6.  The possible role of early post-transplant inflammation in later anemia in kidney transplant recipients.

Authors:  Goran Imamović; Enver Zerem; Safet Omerović; Enes Osmanović; Emir Hodzić
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

7.  Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Authors:  Wattana Leowattana; Srivicha Krudsood; Noppadon Tangpukdee; Gary Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2008-07       Impact factor: 0.267

Review 8.  The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions.

Authors:  Donald S Silverberg; Dov Wexler; Adrian Iaina; Doron Schwartz
Journal:  Clin Exp Nephrol       Date:  2008-08-01       Impact factor: 2.801

9.  Unexplained aspects of anemia of inflammation.

Authors:  Elizabeth A Price; Stanley L Schrier
Journal:  Adv Hematol       Date:  2010-03-24

10.  Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia.

Authors:  Stefan D Anker; Josep Comin Colet; Gerasimos Filippatos; Ronnie Willenheimer; Kenneth Dickstein; Helmut Drexler; Thomas F Lüscher; Claudio Mori; Barbara von Eisenhart Rothe; Stuart Pocock; Philip A Poole-Wilson; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2009-11       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.